| Name | Title | Contact Details |
|---|
Kurbo Health provides the first mobile coaching solution that is designed specifically to help children and families lose weight and develop smarter eating choices. It is based on one of the most advanced weight-management programs from Stanford University, and proven effective in helping kids lose weight and create healthy habits. Kurbo kids and families receive weekly video consults and goal-setting with a trained professional coach via Skype or FaceTime, a mobile app designed to help them track food and exercise on their smartphone, and daily support from a team of experts through emails, text messages, and in-app games and videos. The company has offices in San Francisco and Palo Alto.
In a complex healthcare world, Medline strives to help our customers achieve both clinical and financial success. We do that through a personalized approach to listen and better understand our customers` needs in an environment that tirelessly demands lower costs and better outcomes. We are both a manufacturer and distributor with 1,200 direct sales reps who are dedicated points of contact for customers across the continuum of care. Because of our capabilities and engagement with other clinical and industry thought leaders, we deliver the most robust product portfolio and patient-care solutions to help healthcare providers perform at their very best. Our responsiveness and commitment to advancing the health of healthcare is evident in our actions every day. This is who we are. This is why customers choose us as their trusted business partner.
Core Oncology is a Santa Barbara, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Brown and Toland Physicians Services Organization is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ValenTx was founded with the goal of treating some of the most pervasive health problems of our time: obesity and obesity-related metabolic disorders such as type-2 diabetes and hypertension. Our approach is to create a non-surgical, endoluminal bypass device that builds on the success of established medical interventions, resulting in a highly effective and least-invasive therapy. Current treatments for these diseases include surgery, pharmacology, and medically supervised lifestyle management. The risks, costs, and in some cases poor efficacy of these treatments have hampered their broad adoption by patients, physicians, and payers alike. A truly unmet clinical need exists for a therapy that can deliver the efficacy obtained through surgery, but without the risks and costs associated with surgical intervention. The ValenTx endoluminal bypass therapy mimics the attributes of a Roux-en-Y gastric bypass and is implanted through a non-surgical, endoscopic procedure. This procedure does not require gastric stapling or permanent changes to the patient`s anatomy. The device is removable, replaceable and designed so that the physician could change the therapeutic profile, thereby optimizing the treatment towards the individual patient`s needs. ValenTx has developed a strong intellectual property portfolio, which lies at the foundation of this therapy. The company has successfully conducted a series of clinical studies demonstrating the viability, safety, and efficacy of the therapy.